[11C]-(R)PK11195 tracer kinetics in the brain of glioma patients and a comparison of two referencing approaches
Creators
- 1. University of Manchester, Wolfson Molecular Imaging Centre, Manchester (United Kingdom)
- 2. Imperial College London, ''John Fulcher'' Neuro-Oncology Lab, London (United Kingdom)
- 3. Salford Royal NHS Foundation Trust, Neuropathology Unit, Salford (United Kingdom)
- 4. King's College London, Centre for Neuroimaging, Institute of Psychiatry, London (United Kingdom)
Description
Translocator protein (TSPO) is a biomarker of neuroinflammation that can be imaged by PET using [11C]-(R)PK11195. We sought to characterize the [11C]-(R)PK11195 kinetics in gliomas of different histotypes and grades, and to compare two reference tissue input functions (supervised cluster analysis versus cerebellar grey matter) for the estimation of [11C]-(R)PK11195 binding in gliomas and surrounding brain structures. Twenty-three glioma patients and ten age-matched controls underwent structural MRI and dynamic [11C]-(R)PK11195 PET scans. Tissue time-activity curves (TACs) were extracted from tumour regions as well as grey matter (GM) and white matter (WM) of the brains. Parametric maps of binding potential (BPND) were generated with the simplified reference tissue model using the two input functions, and were compared with each other. TSPO expression was assessed in tumour tissue sections by immunohistochemistry. Three types of regional kinetics were observed in individual tumour TACs: GM-like kinetics (n = 6, clearance of the tracer similar to that in cerebellar GM), WM-like kinetics (n = 8, clearance of the tracer similar to that in cerebral WM) and a form of mixed kinetics (n = 9, intermediate rate of clearance). Such kinetic patterns differed between low-grade astrocytomas (WM-like kinetics) and oligodendrogliomas (GM-like and mixed kinetics), but were independent of tumour grade. There was good agreement between parametric maps of BPND derived from the two input functions in all controls and 10 of 23 glioma patients. In 13 of the 23 patients, BPND values derived from the supervised cluster input were systematically smaller than those using the cerebellar input. Immunohistochemistry confirmed that TSPO expression increased with tumour grade. The three types of [11C]-(R)PK11195 kinetics in gliomas are determined in part by tracer delivery, and indicated that kinetic analysis is a valuable tool in the study of gliomas with the potential for in vivo discrimination between low-grade astrocytomas and oligodendrogliomas. Supervised cluster and cerebellar input functions produced consistent BPND estimates in approximately half of the gliomas investigated, but had a systematic difference in the remainder. The cerebellar input is preferred based on theoretical and practical considerations. (orig.)
Availability note (English)
Available from: http://dx.doi.org/10.1007/s00259-013-2447-2Additional details
Identifiers
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine and Molecular Imaging
- Journal Volume
- 40
- Journal Issue
- 9
- Journal Page Range
- p. 1406-1419
- ISSN
- 1619-7070
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 44105654
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Descriptors DEI
- ASTROCYTOMAS; BIOLOGICAL MARKERS; BRAIN; CARBON 11; CEREBELLUM; CONTRAST MEDIA; GADOLINIUM; GLIOMAS; IMAGE PROCESSING; IN VIVO; INFLAMMATION; NMR IMAGING; POSITRON COMPUTED TOMOGRAPHY; RADIONUCLIDE KINETICS; RADIOPHARMACEUTICALS; SPATIAL RESOLUTION; TRACER TECHNIQUES
- Descriptors DEC
- BETA DECAY RADIOISOTOPES; BETA-PLUS DECAY RADIOISOTOPES; BODY; BRAIN; CARBON ISOTOPES; CENTRAL NERVOUS SYSTEM; COMPUTERIZED TOMOGRAPHY; DIAGNOSTIC TECHNIQUES; DISEASES; DRUGS; ELEMENTS; EMISSION COMPUTED TOMOGRAPHY; EVEN-ODD NUCLEI; GLIOMAS; ISOTOPE APPLICATIONS; ISOTOPES; KINETICS; LABELLED COMPOUNDS; LIGHT NUCLEI; MATERIALS; METALS; MINUTES LIVING RADIOISOTOPES; NEOPLASMS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEI; ORGANS; PATHOLOGICAL CHANGES; PROCESSING; RADIOACTIVE MATERIALS; RADIOISOTOPES; RARE EARTHS; RESOLUTION; SYMPTOMS; TOMOGRAPHY